Triple-Negative Breast Cancer: Stem Cells, Cancer and New Treatment Strategy.

被引:0
|
作者
Yin, S. [1 ]
Xu, L. [1 ]
Reddy, K. B. [1 ]
机构
[1] Wayne State Univ, Sch Med, Detroit, MI USA
关键词
D O I
10.1158/0008-5472.SABCS11-P3-18-05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3-18-05
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Local Treatment of Triple-Negative Breast Cancer
    Machiels, Melanie
    Kaidar-Person, Orit
    Rubio, Isabel T.
    Poortmans, Philip
    CANCER JOURNAL, 2021, 27 (01): : 32 - 40
  • [32] Cannabinoids and triple-negative breast cancer treatment
    Dobovisek, Luka
    Borstnar, Simona
    Debeljak, Natasa
    Brezar, Simona Kranjc
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] The treatment landscape of triple-negative breast cancer
    Hu, Yi
    Wang, Chen
    Liang, Huishi
    Li, Jie
    Yang, Qiong
    MEDICAL ONCOLOGY, 2024, 41 (10)
  • [34] Treatment of Metastatic Triple-Negative Breast Cancer
    Glendenning, Jennifer
    Irshad, Sheeba
    Tutt, Andrew
    CURRENT BREAST CANCER REPORTS, 2012, 4 (01) : 10 - 21
  • [35] Treatment of Metastatic Triple-Negative Breast Cancer
    Jennifer Glendenning
    Sheeba Irshad
    Andrew Tutt
    Current Breast Cancer Reports, 2012, 4 (1) : 10 - 21
  • [36] New Approaches for Triple-Negative Breast Cancer
    不详
    ONCOLOGY-NEW YORK, 2012, 26 (10): : 916 - +
  • [37] New targets in triple-negative breast cancer
    Robert L. Copeland
    Yasmine Kanaan
    Nature Reviews Cancer, 2021, 21 : 744 - 744
  • [38] New targets in triple-negative breast cancer
    Copeland, Robert L.
    Kanaan, Yasmine
    NATURE REVIEWS CANCER, 2021, 21 (12) : 744 - 744
  • [39] New Targets for Triple-Negative Breast Cancer
    Herold, Christina I.
    Anders, Carey K.
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 846 - 854
  • [40] Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
    Lin, Chang-Ching
    Lo, Miao-Chia
    Moody, Rebecca
    Jiang, Hui
    Harouaka, Ramdane
    Stevers, Nicholas
    Tinsley, Samantha
    Gasparyan, Mari
    Wicha, Max
    Sun, Duxin
    CANCER LETTERS, 2018, 438 : 165 - 173